Graypoint LLC’s Barings Corporate Investors MCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$530K Buy
24,455
+475
+2% +$9.75K 0.03% 313
2025
Q1
$562K Buy
23,980
+567
+2% +$11.9K 0.04% 287
2024
Q4
$477K Buy
23,413
+466
+2% +$9.21K 0.03% 316
2024
Q3
$457K Buy
22,947
+478
+2% +$8.85K 0.03% 323
2024
Q2
$418K Buy
22,469
+470
+2% +$8.38K 0.03% 317
2024
Q1
$378K Buy
21,999
+452
+2% +$8.25K 0.03% 334
2023
Q4
$397K Buy
21,547
+472
+2% +$7.86K 0.03% 297
2023
Q3
$336K Buy
+21,075
New +$323K 0.03% 305

Other funds holding MCI

Graypoint LLC's MCI Position: Q2 2025 in Review

Graypoint LLC increased its Barings Corporate Investors (MCI) stake by 2% in Q2 2025, buying an estimated $9.75K and bringing the position to 24,455 shares worth $530K. The position accounts for 0.03% of the portfolio, ranked #313.

Graypoint LLC first reported a position in MCI in Q3 2023 and has held it in 8 quarters since. The position peaked at $562K in Q1 2025. 65 funds tracked by Wall St. Rank hold MCI as of Q2 2025.

  • Graypoint LLC held 24,455 shares of Barings Corporate Investors worth $530K as of Q2 2025.
  • Graypoint LLC bought 475 Barings Corporate Investors shares in Q2 2025, an estimated $9.75K.
  • Barings Corporate Investors made up 0.03% of Graypoint LLC's portfolio in Q2 2025, its #313 holding.
  • Graypoint LLC first reported a position in Barings Corporate Investors in Q3 2023 and has held it in 8 quarters since.
  • Graypoint LLC's Barings Corporate Investors position peaked at $562K in Q1 2025.
  • 65 funds tracked by Wall St. Rank held Barings Corporate Investors as of Q2 2025.

Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.